Obesity Trial, Recruiting NCT06824974 Sponsor: University of California, San Diego Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06824974
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a Body Mass Index (BMI) between 27 and 45, meaning they are overweight or obese
  • People who have been diagnosed with a liver condition, specifically fatty liver disease (MASLD/NAFLD), liver inflammation related to metabolic issues (MASH), cirrhosis, or an early-to-intermediate stage of liver cancer (HCC)
  • People who are 18 years of age or older and speak English or Spanish
  • People whose overall physical functioning meets a certain level, meaning they are able to carry out at least some daily activities (confirm with trial site)
  • People whose usual overnight fast is currently less than 12 hours
  • People who are willing to follow all study procedures throughout the trial
  • People with a life expectancy of more than 12 months

Who may not be able to join:

  • People with advanced liver cancer, cancer that has progressed significantly, or serious related health complications
  • People whose cancer has spread to other parts of the body, has grown into blood vessels, or who have fluid build-up in the abdomen (ascites)
  • People with advanced cirrhosis, including low blood protein levels or a Child-Pugh score of B or C (a measure of liver disease severity — confirm with trial site)
  • People with severe, hard-to-control brain function problems caused by liver disease (hepatic encephalopathy, grade 3–4)
  • People with Type 1 diabetes, or those who have experienced low blood sugar episodes
  • People currently enrolled in another study that requires changes to diet or meal timing
  • People currently taking GLP-1 receptor agonist medications (a type of medication used for diabetes or weight management)
  • People with uncontrollable or disordered eating patterns, significant unintentional weight loss, Night Eating Syndrome, or food insecurity
  • People taking medications that would significantly affect the biological measurements being studied in this trial (confirm with trial site)
  • People who have had another type of cancer in the past 10 years, with the exception of certain non-invasive skin or cervical cancers
  • People with serious ongoing medical conditions such as chronic kidney disease, heart failure, or any condition that could interfere with taking part in the trial
  • People who have unresolved side effects of grade 2 or higher from previous cancer treatment (confirm with trial site)
  • People with active alcohol misuse, or who have been sober for less than 6 months
  • People who have taken part in a trial of an experimental treatment within the past 30 days
  • People who are pregnant, breastfeeding, or who have a positive pregnancy test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nick Webster, PhD, Universoty of California San Diego

Phone: 858-534-6275

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence to protocol; Safety from adverse events; Ability to recruit; Satisfaction and self-motivation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov